FDA inspection
Coherus Oncology, Inc.: FDA inspection ending Mar 16, 2017
FDA inspection 1006775 · No Action Indicated (NAI) · Redwood City, CA
Key facts
| Inspection ID | 1006775 |
|---|---|
| Firm | Coherus Oncology, Inc. |
| FEI number | 3009682611 |
| Address | 333 Twin Dolphin Dr Ste 600 |
| City | Redwood City |
| State | CA |
| ZIP | 94065 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Mar 16, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data